Pfizer and UCL to develop stem-cell therapies for AMD; Clarient licenses breast cancer biomarkers from Indiana U; Nanosys and Harvard to outlicense nanowire IP; Luminex settles with SUNY and U of Illinois, and more …
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.